Introduction
Measuring health outputs is important -unless one is from those schools of thought that argue that it is not possible to measure health status, that it is 'just constructing castles on sand' (1); or that it is dangerous to do so (2) . This paper accepts the importance of attempting to measure QALYs -quality adjusted life years -but questions whether they are adequate in measuring all that we would wish to measure in the interest of both health service goals and individual patient welfare.
To that extent the paper represents both a defence and a critique of some aspects of QALYs. However, it does not join John Rawles (3) (in this issue of JME) in 'castigating QALYs'. Since at least some of his criticisms are none the less relevant to my defence in principle of QALYs, I have discussed these in the next section of this paper.
The underlying premise of my paper is that QALYs per se do not create any ethical problems (or at least do not add to existing ones) in health care decisionmaking. However, they may if it is assumed that 'maximising QALYs' can embrace the equity goals of health care and if health is assumed to be the only output of health services.
The paper beyond this introduction is in four parts. Section 2 castigates Rawles. Some theoretical issues surrounding utility are considered in Section 3. Section 4 discusses the relationship of QALY maximisation to health service objectives. Finally there is a brief conclusion.
There are various issues related to QALYs that are not raised in this paper. Most important of the omissions is the handling of risk and uncertainty. Much of the literature on QALYs assumes that the relevant decision-makers are risk-neutral (ie expected utility is equal to the 'objective' probability that a particular health state will occur multiplied by the utility associated with that health state). This somewhat questionable and important assumption is not dealt with here.
Castigating Rawles
Rawles is so indiscriminately critical of QALYs that it is difficult to see what his fundamental objections are. Here I want to discuss some possibilities.
(i) QALYs attempt to measure the immeasurable. That does not seem to be the objection -since he is concerned that life is relatively undervalued by QALYs vis-a-vis suffering which implies at least that he accepts that quantity and quality of life can be weighed against each other.
(ii) QALYs use values with which he disagrees. That certainly seems to be one of his objections against the Kind et al (4) QALYs (but note that there are other QALYs: see for example the work of Torrance (5) Let us take a simple example. Assume that 100 lives can be saved by each of five different treatments, A to E. A costs £10,000, B £20,000, C £30,000, D £40,000 and E £50,000. Now if we select 100 lives to save randomly -the Rawles approach -then the expected cost will be £3 million (20 of each of A, B, C, D and E being equal to £200,000 + £400,000 + £600,000 + £800,000 + £1,000,000). People are thus not 'penalised' because they have expensive illnesses, nor favoured because their problems are cheap to treat.
But we could save 200 lives for £3m ie 100 of A and 100 of B or we could save 100 lives (A lives) for £1m and have £2m 'savings' for reducing suffering elsewhere. This Rawles's theory of justice is expensive in terms of death and suffering. He places a very high weight on equity. There is frequently a conflict between equity and efficiency and that means that some trade-off is then necessary. Whether the Rawles's weight on equity is too great is open to debate.
However, the economist's approach at least then poses the question: are you John Rawles prepared to sacrifice 100 lives in the cause of justice? Economists cannot or at least should not qua economists attempt to answer such a question ( I am not even sure that it is for clinicians to answer it) but they would argue that it is advantageous to pose it. Similarly when Rawles wants 'prolongation of life' to have 'overriding priority' economists with their QALYs simply want to ask him to quantify ' The implicit assumption built into QALYs appears to be (this is more contentious) that it is only outcomes that matter and there is no utility attached to process (for example the decision-making process). For example, Dowie (6) states: 'QALYs ... assume the only relevant utilities produced from procedures are outcome-based. So that the "process" involved in the procedure isn't regarded as in itself generating utility or disutility'.
Further and perhaps still more contentious, QALYs are normally based on expected utility theory. Explicitly, this means that it is the utilities associated with the consequences of the described states of the world that are deemed relevant. In other words and inter alia the utility associated with health state Hn, is independent of Hj, the health state one is in when the judgement is made. Further when the question of choice is explicitly considered and there is a range of possible outcomes, with various attached probabilities, then the state(s) of the world not chosen do not affect the utility obtained from the state of the world attained. Translated into health status or QALY terms, these considerations mean that (i) only health status is relevant;
(ii) the utility of an expected or possible health state is independent of current health state (and at least in some forms -see Kind, Rosser and Williams (4) -independent of future expected health state ie prognosis); (iii) related to (ii) nominally equal changes in health state are valued equally whether they are gains or losses, except for the sign; (iv) the utility associated with the health states possible but not selected does not enter the consumer's/patient's (doctor agent's?) utility function. 3.2 Some (possible) solutions? The above comments are not arguments against measuring health outputs. I am in favour of measuring health outputs. Rather I am contending that insofar as QALYs are built on expected utility theory they may suffer from certain weaknesses. There are other possible theories here that merit investigation such as regret theory (see Loomes and Sugden, (7)) and prospect theory (see Kahneman and Tversky, (8)).
Space does not allow detailed consideration of these theories here. However, it is relevant to give a flavour of what they involve. Regret theory for example allows disutility because the individual knows (ex post) that he/she could have had a better outcome. Prospect theory focusses on change thereby allowing current health status to influence valuations of other health states. (An individual may value the state of blindness in both eyes differently depending on whether that person has the sight of two eyes now or of only one eye now.)
There are potential advantages in these approaches. That is not so important in itself. Rather it suggests that there is a need for research on QALYs at least to recognise the existence of these other theories and to consider their relative merits. 4 Culyer further suggests, in an attack on equality defined by him (normally) as equality of provision per head, that 'the equality argument is really masquerading as an efficiency argument...' on the basis that, for example, the marginal pay-off in terms of health per pound is greater among the poor than the rich.
There is some doubtful logic here. First, I know of no country which has as its stated equity policy in health care the objective of equality of provision per head; and know of no 'egalitarians' (Culyer's terminology) who advocate such an equity objective. Second, the fact that the marginal pay-off in terms of health per pound for the poor is higher than for the rich does not lead to any masquerading. Of course, I can agree that spending on the poor rather than the rich may be efficient and may lead to overall greater health but I can still support some concept of equity over and above that.
Culyer's claim that 'egalitarianism equals national health maximising' is only tenable if (and there are other, less relevant, conditions here) it is accepted that health care is only about health. It seems to be a somewhat circular argument -but it appears to be the one on which the QALY pliers base their arguments that QALYs can adequately embrace equity.
But how best can equity be considered in health care? Is there an alternative to the QALY maximisers? Here I want to extend a theory advocated by Margolis (11) and which I have addressed at greater length elsewhere (Mooney, (12) ). Margolis postulates the idea of self-interested man and group-interested man within the same individual, ie each individual has two (internal) utility functions between which he allocates his resources. One is concerned with purely selfish utility (S-utility) which is a conventional utility function in that the individual derives utility from the spending on his own private goals. The other (Gutility) is concerned with utility derived from contributing to or participating in some group activity, ie is a form of process utility with utility gained from the process of participation. The individual allocates his resources between these two utility functions in such a way as to maximise his utility. The distinctive contribution of the theory relates to the definition of utility such that the individual derives satisfaction from participating -from doing his fair share.
There are features of the provision of health careuncertainty, irrationality, unpredictability, ignorance, externalities -which make it a particularly strong candidate for group interest.
Regarding equity, under the 'fair share' approach, the individual seeks to ensure that he is in equilibrium regarding his allocation both selfishly and to the group. He obtains outcome utility in the former, and process utility in the latter. Given that both forms of utility are present and that the group contains the individual as an equal then it is enough for the individual simply to care about providing access to health care. Whether other individuals out of selfish interest then utilise the group resources is not relevant to the individual. Given commonality of group interest this will point to equality of access for equal need for members of the group, leaving the selfish interest of different individuals to determine the value placed on health and health care and hence individuals' consumption and thereby health.
One particular advantage of this approach to equity vis-a-vis the QALY pliers is that equality of access which is not considered relevant in QALY maximisation is both the dimension ofequity emerging from the Margolis model and, importantly, the most common dimension of health care policy statements.
QALYs, infonnation and decision-making
What has been said in the previous sub-section has cast doubt on whether equity can be contained adequately in a welfare function that consists solely of QALYs. But there are other potential utility-bearing characteristics of the commodity health care that may be relevant, particularly at the clinical and individual patient level. Elsewhere (13) together with others I have argued that health is not the only relevant utility bearer in health care.
Additionally health care is about the provision of information and about decision-making. Doctors act as agents on behalf of patients who lack information about their health status, the availability of treatments and their effectiveness. Patients are generally more ignorant about health care than about many other commodities. As such they may look to the doctor to provide not just treatment which they expect will improve their health status (more QALYs) but also information which may have no effect directly on their health status.
It is also the case that patients may seek help from their doctor in the actual decision-making process. The uncertainty surrounding health care consumption decisions can be great and patients may welcome the opportunity to pass difficult decision-making to the doctor -even if doing so does not directly affect their health status.
Consequently it would seem that there is a danger that QALYs may be assumed to be all that the output of health care is about. This is open to question. (That, it must be noted, does not make QALYs redundant. Rather it means (a) that they are not enough and (b) that marginal cost per QALY may not be an adequate ranking device in setting priorities in health care.)
What does the evidence show? Is there more than health in health care consumers' utility functions? Studies by Berwick and Weinstein (14) on the value of information in ultrasound and by Strull et al (15) on attitudes of patients to information and decisionmaking would suggest that patients may well wish to have information and decision-making components included in their utility functions.
Conclusion
Whatever it is that health services are producing is complex. Whatever it is, as an economist, I wish to support the notion of efficiency in its production -the idea ofmaximising the benefit or utility to society from the resources available subject to the possible constraint of doing so equitably if that is a social goal.
Consequently I support the idea of using QALYs as a mechanism for trying to measure the health outputs of health care. However, I would dispute two things: (i) that maximising QALYs will necessarily embrace equity: it will not-indeed cannot -if the equity goal is couched in terms of equal access; and (ii) that maximising QALYs is the same as maximising utility or benefit since it is my belief that there are other nonhealth outputs that are frequently considered as benefits from the health care system. QALYs need to be developed, improved. They need to be better understood. Those who prefer to ignore the scarcity of resources and allocate solely on the basis of need, or on the basis of the severity of the problem, or by MSW or by clinical judgement alone will of course be less ready to accept QALYs and more willing to agree with the arguments put forward by John Rawles.
QALYs -with qualifications -is my preferred choice. More important than my preferred choice and more important than John Rawles's preferred choice, however, is the fact (which I think we can all agree on) that how rationally to set priorities in health care is now clearly on the agenda. It is largely the debate about QALYs that has achieved that. Developing QALYs in both principle and practice is now the goal.
